Tesaro Inc (TSRO) Financial Statements (2025 and earlier)

Company Profile

Business Address 1000 WINTER STREET, SUITE 3300
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments575,104498,980643,095521,265507,941672,239
Cash and cash equivalent575,104498,980643,095521,265507,941672,239
Receivables35,67944,18253,41627,68023,1496,061
Inventory, net of allowances, customer advances and progress billings87,40674,44457,93950,52728,28515,643
Inventory87,40674,44457,93950,52728,28515,643
Asset, held-for-sale, not part of disposal group 22,299     
Other current assets36,92438,18433,51122,25723,04513,625
Total current assets:757,412655,790787,961621,729582,420707,568
Noncurrent Assets
Property, plant and equipment10,65710,2729,6529,8779,9588,618
Intangible assets, net (including goodwill)36,62454,94756,38443,15544,40837,387
Intangible assets, net (excluding goodwill)36,62454,94756,38443,15544,40837,387
Restricted cash and investments2,5562,5562,5522,5212,5222,316
Other noncurrent assets3,2046,1275,6368,4366,0875,116
Total noncurrent assets:53,04173,90274,22463,98962,97553,437
TOTAL ASSETS:810,453729,692862,185685,718645,395761,005
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities172,372155,668158,980129,06099,63479,318
Accounts payable12,9255,0794,1725,9844510,343
Accrued liabilities159,447150,589154,808123,07699,58968,975
Other liabilities11,3717,4516,9022,2872,7013,264
Deferred revenue and credits 959595
Contract with customer, liability437 
Other undisclosed current liabilities  117324  24,790
Total current liabilities:184,180163,236166,206131,442102,430107,467
Noncurrent Liabilities
Long-term debt and lease obligation639,918440,417437,105   
Long-term debt, excluding current maturities639,918440,417437,105   
Liabilities, other than long-term debt7,9038,1239,5776,5535,6045,798
Deferred revenue and credits 235258282
Contract with customer, liability164 
Other liabilities7,7398,1239,5776,3185,3465,516
Other undisclosed noncurrent liabilities  188211140,362137,447134,532
Total noncurrent liabilities:647,821448,728446,893146,915143,051140,330
Total liabilities:832,001611,964613,099278,357245,481247,797
Equity
Equity, attributable to parent(21,548)117,728249,086407,361399,914513,208
Common stock555555
Additional paid in capital1,785,6961,755,7831,724,8501,697,5441,664,9971,626,533
Accumulated other comprehensive loss(7,895)(5,357)(5,882)(2,366)(2,543)(2,844)
Accumulated deficit(1,799,354)(1,632,703)(1,469,887)(1,287,822)(1,262,545)(1,110,486)
Total equity:(21,548)117,728249,086407,361399,914513,208
TOTAL LIABILITIES AND EQUITY:810,453729,692862,185685,718645,395761,005

Income Statement (P&L) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues57,20849,74248,023142,76629,4643,073
Revenue, net 142,76629,4643,073
Cost of revenue
(Cost of Product and Service Sold)
(13,513)(9,997)(30,857)(6,216)(3,620)(444)
Gross profit:43,69539,74517,166136,55025,8442,629
Operating expenses(212,652)(201,796)(223,693)(164,856)(177,978)(136,318)
Other undisclosed operating income13,5139,99730,8576,2163,620444
Operating loss:(155,444)(152,054)(175,670)(22,090)(148,514)(133,245)
Nonoperating income1,6151,7461,2991,376959841
Investment income, nonoperating1,5341,6651,2141,133959841
Other nonoperating income818185243  
Interest and debt expense(12,830)(12,092)(6,641)(4,424)(4,426)(4,267)
Loss from continuing operations before equity method investments, income taxes:(166,659)(162,400)(181,012)(25,138)(151,981)(136,671)
Other undisclosed income from continuing operations before income taxes      
Loss from continuing operations before income taxes:(166,659)(162,400)(181,012)(25,138)(151,981)(136,671)
Income tax expense (benefit)8(416)(1,053)(139)(78)(54)
Loss from continuing operations:(166,651)(162,816)(182,065)(25,277)(152,059)(136,725)
Loss before gain (loss) on sale of properties:(166,651)(162,816)(182,065)(25,277)(152,059)(136,725)
Net loss available to common stockholders, diluted:(166,651)(162,816)(182,065)(25,277)(152,059)(136,725)

Comprehensive Income ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net loss:(166,651)(162,816)(182,065)(25,277)(152,059)(136,725)
Other comprehensive income61633,222464645
Comprehensive loss:(166,590)(162,753)(178,843)(25,231)(152,013)(136,680)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2,598)462(6,738)13125535
Comprehensive loss, net of tax, attributable to parent:(169,188)(162,291)(185,581)(25,100)(151,758)(136,645)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: